Rein Therapeutics
RNTX
$3.05
Share price
0.00%
Change (1 day)
-70.38%
Change (1 year)
Categories
EPS for Rein Therapeutics (RNTX)
EPS in 2024 (TTM): -$3.27
According to Rein Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.56. In 2023 the company made an earnings per share (EPS) of -$6.14 an increase over its 2022 EPS that were of -$10.81.
EPS history for Rein Therapeutics from 2015 to 2024
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2024 (TTM) | -$3.27 | -46.71% |
| 2023 | -$6.14 | -43.19% |
| 2022 | -$10.81 | 2.21% |
| 2021 | -$10.58 | -51.72% |
| 2020 | -$21.91 | -49.17% |
| 2019 | -$43.10 | -43.93% |
| 2018 | -$76.86 | -29.61% |
| 2017 | -$109.18 | 82.33% |
| 2016 | -$59.88 | 40.54% |
| 2015 | -$42.61 |